Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 279
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00370240 | Chlorhydrate of Ropivacaine and Breast Cancer Surgery | ||
| NCT06508216 | A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer | ||
| NCT04276376 | Efficacy and Safety of the Combination of Rucaparib (PARP Inhibitor) and Atezolizumab (Anti-PD-L1 Antibody) in Patients With DNA Repair-deficient or Platinum-sensitive Solid Tumors | ||
| NCT04477681 | Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults | ||
| NCT03308604 | AGuIX Gadolinium-based Nanoparticles in Combination With Chemoradiation and Brachytherapy | ||
| NCT02230176 | Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II | ||
| NCT05889585 | Morbidity, Long-term Side Effects and Quality of Life in Germ-cell Tumor Long Survivors Treated with High-dose Chemotherapy and Autologous Stem Cell Transplant | ||
| NCT00407433 | Clinical Studies of Gemcitabine-Oxaliplatin | ||
| NCT01834950 | Identification of Early Markers of Response and Resistance to Trastuzumab | ||
| NCT06781996 | A Study to Determine the Efficacy of a Digital Self-management Support Tool to Improve the Quality of Life During Adjuvant HOrmonal Therapy for Patients With Early Breast Cancer | ||
| NCT01403324 | Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer | ||
| NCT01540058 | Trial Comparing a Strategy Based on Molecular Analysis to the Empiric Strategy in Patients With CUP | ||
| NCT03356535 | Metabolic Signature of Healthy Lifestyle and HCC | ||
| NCT05071001 | Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or Adolescence | ||
| NCT01371201 | First International Randomized Study in Malignant Progressive Pheochromocytoma and Paraganglioma | ||
| NCT00002858 | Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer | ||
| NCT00180908 | Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children | ||
| NCT00005062 | Radiation Therapy in Patients With Limited-Stage Small Cell Lung Cancer in Complete Remission | ||
| NCT00852228 | Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy | ||
| NCT01884623 | Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer | ||
| NCT06957132 | Analysis of Risk Factors for Hearing Loss in Survivors of Cancer Occurred During Childhood, Adolescence or Young Adulthood | ||
| NCT02997332 | Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma | ||
| NCT01864850 | Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC | ||
| NCT00180947 | Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse | ||
| NCT02673268 | Robot Assisted Mastectomy Via Axillary Way With Areola Conservation and Immediate Reconstruction | ||
| NCT00433706 | Image Guided Radiation Therapy For Prostate Cancer | ||
| NCT05705791 | Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma | ||
| NCT01857453 | Interest of a Dose Decrease for Radiotherapy Associated With Chemotherapy for Treatment of Standard Risk Adult Medulloblastomas | ||
| NCT03010124 | Prognostic and Predictive Biomarkers in Ovarian Cancers | ||
| NCT00181051 | Clinical Utility of the Alaris MidLatencyAuditoryEvoked Potentials Monitor to Titrate the Anesthetic-Hypnotic Component of Anesthesia | ||
| NCT01112254 | Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer | ||
| NCT01887522 | Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults | ||
| NCT00367861 | Prospective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs Maintenance | ||
| NCT02666612 | Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer | ||
| NCT00180895 | Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL | ||
| NCT03803735 | Hospital Based Registry of Childhood Cancer in Pediatric Oncology Units in French Speaking Africa | ||
| NCT00126230 | Trial of Docetaxel-Samarium in Patients With Hormone-Refractory Advanced Prostate Cancer | ||
| NCT03918655 | MIF Involvement in AML | ||
| NCT01516580 | Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients | ||
| NCT07016230 | Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB) | ||
| NCT06439888 | Lymphocyte Support to SBRT in Patients With Oligo-metastatic Solid Cancer | ||
| NCT00552149 | Biliary Cancers: EGFR INhibitor, Gemcitabine and Oxaliplatin | ||
| NCT07159451 | A Short-term Preoperative, Evaluating Activity and Safety of Elacestrant Monotherapy as Compared to Elacestrant + Ovarian Function Suppression (LHRH Agonist) in Premenopausal Patients With Stage I-II ER+/HER2- Breast Cancer | ||
| NCT00181025 | Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle | ||
| NCT04965766 | Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer | ||
| NCT05912075 | Preoperative Radiotherapy And ASTX660 in Rectum Cancer | ||
| NCT06642844 | Bevacizumab-based Chemotherapy Adapted to Bevacizumab Pharmacokinetics in 1st-line Treatment | ||
| NCT05283044 | Implementing Precision Medicine in cOmmunity HospiTALs | ||
| NCT02679963 | Trial Evaluating Maintenance Olaparib in Patients With Platinum-sensitive Advanced Non-small Cell Lung Cancer | ||
| NCT05631249 | Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C |
